For the Inventor, By the Inventor

Enter assignee name

Herstal, Belgium

Mdxhealth, Sa

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 10

Trademarks = 17

Forward Citations = 43

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Wim Van Criekinge (6 out of 7 patents)

Katja Bierau (4 out of 8 patents)

Ilse Vlassenbroeck (3 out of 3 patents)

4. Joost Louwagie (2 out of 6 patents)

5. Isabelle Renard (2 out of 2 patents)

6. Valerie Deregowski (2 out of 2 patents)

7. Luc Dehaspe (2 out of 2 patents)

8. G Bea A Wisman (2 out of 2 patents)

9. Ate G J Van Der Zee (2 out of 2 patents)

10. E M D Schuuring (2 out of 2 patents)

11. Manon Van Engeland (1 out of 5 patents)

12. Arjan Griffioen (1 out of 7 patents)

13. Manon Adriaan De Bruine (1 out of 5 patents)

14. Gontran Brichard (1 out of 5 patents)

15. Maarten Penning (1 out of 5 patents)

12 patents: Sort by Forward Citations

1. 11767563 - Method for predicting and treating clinically significant prostate cancer (2023-09-26),

2. 10119166 - Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples (2018-11-06),

3. 10113202 - Method for determining the methylation status of the promoter region of the TWIST1 gene in genomic DNA from bladder cells (2018-10-30),

4. 10053724 - Methylation detection of the MGMT promoter (2018-08-21),

5. 10041128 - Methylation of the EPB41L3 gene or the promoter of the EPB41L3 gene in a test sample comprising cervical cells (2018-08-07),

6. 9605312 - Methods of detecting mutations in BRAF and epigenetic changes (2017-03-28),

7. 9388471 - Methylation of the GATA4 gene in urine samples as a marker for bladder cancer detection (2016-07-12),

8. 9371569 - Detection and prognosis of cervical cancer (2016-06-21),

9. 9322065 - Methods for determining methylation of the TWIST1 gene for bladder cancer detection (2016-04-26),

10. 9050280 - Methylation detection of MGMT (2015-06-09),

11. 8969046 - Methods for detecting epigenetic modifications (2015-03-03),

12. 8481700 - Detection of mage-A expression (2013-07-09),

MDxHealth is a multinational healthcare company that specializes in molecular diagnostics for cancer. They develop and commercialize advanced tests that provide information to healthcare providers to make more accurate and personalized treatment decisions for their patients. With a focus on improving patient outcomes and reducing healthcare costs, MDxHealth is committed to advancing the field of precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

12 Patents

#4 in Herstal

#224 in Belgium

#46,685 in the World

Herstal, Belgium

Mdxhealth, Sa

Forward Citations = 43

21 inventors:

Wim Van Criekinge (6 out of 7 patents)

Katja Bierau (4 out of 8 patents)

Ilse Vlassenbroeck (3 out of 3 patents)

4. Joost Louwagie (2 out of 6 patents)

5. Isabelle Renard (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…